Vanterra Ventures Research
Investment Thesis
Vanterra Ventures (VV) is a venture and growth equity fund investing in the "Future of Consumer Health." The firm partners with visionary founders building disruptive companies across three stated categories: branded products, digital health, and enabling technologies. VV was formed in 2019 by Vanterra Capital, a private equity investment firm founded in 2008 that develops specialized investment platforms, to apply Vanterra Capital's private equity playbook to the consumer health opportunity. The firm is headquartered in New York with a second office in Coral Gables, Florida (Miami). VV's portfolio spans nutraceutical and supplement brands, functional food and beverage, telehealth and virtual care platforms, and technology-enabled services that support consumer health brands.
Stage Focus
Evidence from disclosed rounds spans seed through Series B. VV was a new seed investor in Grüns ($6M seed, February 2024), led a $15M Series A in Cove Soda (November 2025), and co-led a $5.5M raise in Fort Health alongside Twelve Below (November 2024, bringing Fort Health's total raised to $16M). The firm also appears as an existing/select investor in Allara Health's later rounds (a $10M Series A and subsequent $26M Series B led by Index Ventures). This spread indicates a Seed through Series B focus, with a willingness to both initiate and follow on in rounds.
Check Size
No explicit check-size range is published on the firm's site or in available press materials. Round sizes VV has participated in range from roughly $5.5M to $15M+ at the round level, but VV's specific allocation within multi-investor rounds is not disclosed, so a confident check-size figure cannot be extracted.
Lead Tendency
Vanterra Ventures both leads and follows. It is explicitly credited as sole lead investor in Cove Soda's $15M Series A ("led by Vanterra Ventures"), and as co-lead (with Twelve Below) in Fort Health's $5.5M raise. In other portfolio companies, such as Grüns and Allara Health, it appears as a participating/select investor rather than lead.
Recent Activity
VV has been actively engaged with its portfolio through 2025 and into 2026. The highest-signal recent event is the acquisition of portfolio company Grüns (a greens/gummy supplement brand) by Unilever, announced April 9, 2026, for approximately $1.2B — a strong exit less than three years after Grüns's 2023 founding and roughly two years after VV's seed investment. Other recent activity includes Cove Soda's $15M Series A (November 2025, led by VV), Mixlab's launch of its "Maisy" AI health partner product (January 2026), Allara Health's expansion to all 50 states (October 2025), and Mixlab's acquisition of The Pet Apothecary and SBH Medical's veterinary business to expand Midwest operations (January 2025, with continued VV backing alongside PLUS Capital). Third-party fund data (privatefunddata.com) lists Vanterra Ventures Fund II, LP with approximately $72.1M in gross assets, consistent with an actively deploying early/growth-stage fund.
Portfolio Highlights
Notable portfolio companies include Grüns (acquired by Unilever for ~$1.2B in 2026 — VV's most significant disclosed exit), Allara Health (women's hormonal/metabolic telehealth, expanded to all 50 states, backed by Index Ventures and GV in later rounds), Mixlab (modern veterinary pharmacy platform, tripled its Midwest network via acquisition and launched an AI product), Cove Soda (Canada-based functional soda, VV-led Series A backed by a notable roster of athlete/celebrity co-investors including Miles Teller, Kygo, The Chainsmokers, and Michael Rubin), Fort Health (pediatric behavioral/mental health), Arrae (supplement brand recognized among "Most Powerful Beauty Brands" of 2025), Actual Veggies (veggie-forward frozen food), Jolly (employee rewards platform, backed by ex-Tesla CFO Zach Kirkhorn), Daily Harvest, Bombas, Naadam, HumanCo, Golde, Dose, BIOHM Health, Milamend, Journey Clinical, Jupiter, CGM Me (Glider, a gamified continuous glucose monitoring app), Misen, HU Kitchen, Moku Foods, and Cleancult.
Team
- Shad F. Azimi — Founder & Managing Partner
- Alejandro Weinstein — Partner
- Trevor Rechnitz — Partner
- Elizabeth Yang — Senior Associate
- Ryan Euell — Chief Financial Officer
- Vanessa Gil — Head of Investor Relations
- Jessica Burton — Chief Administrative Officer
- Olivia Boe — Undergraduate Associate
Decision Process
With a Founder/Managing Partner and two additional Partners, plus a dedicated CFO and Head of Investor Relations, VV operates as a multi-partner investment team rather than a solo-GP structure, consistent with its parent Vanterra Capital's institutional private equity background. Decisions likely run through the partnership rather than a single individual, though no formal investment committee process is disclosed publicly.
Founder Preferences
VV explicitly favors "visionary founders building disruptive companies" in consumer health, spanning branded product founders (Grüns, Cove Soda, Arrae, Actual Veggies), clinical/telehealth founders (Allara Health, Fort Health, Journey Clinical), and technology-enabled service founders (Mixlab, CGM Me). Several portfolio companies carry notable athlete and celebrity backing alongside VV (Cove Soda's investor roster includes Miles Teller, Jack Eichel, and JD Martinez), suggesting VV is comfortable co-investing in high-visibility, culturally-driven consumer brands.
Geographic Focus
VV's disclosed portfolio is concentrated in North America, primarily the United States, with at least one Canada-based investment (Cove Soda). The firm's offices in New York and Miami align with a US-centric deal sourcing and portfolio footprint.
Sector Focus
VV organizes its own portfolio into three categories displayed on its site: Branded Products, Digital Health, and Enabling Technologies. Branded Products skews toward nutraceuticals/supplements and functional food and beverage; Digital Health includes telehealth, women's hormonal health, pediatric mental health, and consumer-facing chronic-condition management (diabetes/CGM); Enabling Technologies includes portfolio companies like Mixlab that provide technology-enabled infrastructure supporting consumer health brands and providers.